PS35: PROFILE OF THE PATIENT IN ARIPIPRAZOL TREATMENT – CLINICAL EXPERIENCES FROM CHILD AND ADOLESCENT PSYCHIATRY

Lobby

AUTHORS
Beata Diomsina1, Pernille Darling Rasmussen2

1Vilnius University Medical Faculty Psychiatric Clinic, Vilnius, Lithuania
2Child and Adolescent Psychiatric Clinic, Holbaek, Denmark

ABSTRACT DESCRIPTION

Objective: The aim of this study is to share clinical experience with Aripiprazol (Abilify) in treatment of children and adolescents.

Method: The sample (n=33) consists of children and adolescent patients (age 9-18) in treatment with abilify at the Child and Adolescent Psychiatric Clinic 1 (Roskilde, Denmark) in June 2013. All diagnoses were included and covered severe conduct problems (high impulsivity, aggression, outward reaction, and physical cross-border behavior), high restlessness with ADHD, psychotic and psychosis-like symptoms with autistic disorders, psychosis, and intensive tics with Tourette’s syndrome. The study was conducted as a Cross-sectional study with detailed description of all patients included.

Poster Session